MultiPlan Co. (NYSE:MPLN – Get Free Report) was the target of a large decrease in short interest during the month of December. As of December 15th, there was short interest totalling 302,600 shares, a decrease of 13.7% from the November 30th total of 350,700 shares. Based on an average daily trading volume, of 112,900 shares, the days-to-cover ratio is currently 2.7 days. Approximately 4.6% of the shares of the stock are short sold.
Wall Street Analysts Forecast Growth
Separately, Citigroup reduced their price target on shares of MultiPlan from $17.20 to $10.00 and set a “neutral” rating on the stock in a research note on Monday, September 23rd.
Check Out Our Latest Report on MultiPlan
MultiPlan Trading Down 12.8 %
Institutional Inflows and Outflows
A number of large investors have recently added to or reduced their stakes in MPLN. Fore Capital LLC bought a new position in shares of MultiPlan during the second quarter valued at $37,000. Point72 DIFC Ltd acquired a new position in MultiPlan during the 2nd quarter worth about $43,000. Cubist Systematic Strategies LLC acquired a new position in MultiPlan during the 2nd quarter worth about $72,000. Hsbc Holdings PLC grew its position in shares of MultiPlan by 68.7% in the 2nd quarter. Hsbc Holdings PLC now owns 218,459 shares of the company’s stock valued at $87,000 after buying an additional 88,944 shares during the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of MultiPlan in the second quarter valued at about $245,000. Institutional investors own 87.15% of the company’s stock.
MultiPlan Company Profile
MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services.
Recommended Stories
- Five stocks we like better than MultiPlan
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- 3 Stocks Helping to Bring AI to Healthcare
- What Do S&P 500 Stocks Tell Investors About the Market?
- 3 Stocks Ringing in The New Year With Large Buyback Announcements
- What is a Dividend King?
- Why 2024 Was Great for Stocks—and Why 2025 Could Be Even Better
Receive News & Ratings for MultiPlan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MultiPlan and related companies with MarketBeat.com's FREE daily email newsletter.